Your browser doesn't support javascript.
loading
Oncoplastic Surgery Outcomes in the Older Breast Cancer Population: A Matched-Cohort Comparison Study.
Gaffney, Kerry A; Karamchandani, Manish M; De La Cruz Ku, Gabriel; Wareham, Carly; Homsy, Christopher; Nardello, Salvatore; Chatterjee, Abhishek; Persing, Sarah M.
Affiliation
  • Gaffney KA; From the Department of Surgery, Tufts Medical Center, Boston.
  • Karamchandani MM; From the Department of Surgery, Tufts Medical Center, Boston.
  • Wareham C; From the Department of Surgery, Tufts Medical Center, Boston.
  • Homsy C; Division of Plastic and Reconstructive Surgery.
  • Nardello S; Division of Surgical Oncology and Breast Surgery, Department of Surgery, Tufts Medical Center, Boston, MA.
Ann Plast Surg ; 93(2): 183-188, 2024 Aug 01.
Article in En | MEDLINE | ID: mdl-38980943
ABSTRACT

BACKGROUND:

Oncoplastic breast surgery (OBS) is a form of breast conservation surgery (BCS) that involves a partial mastectomy followed by immediate volume displacement or volume replacement surgical techniques. To date, there are few studies evaluating OBS in older patients. Therefore, we sought to determine if outcomes differed between patients 65 years and older versus younger patients who underwent oncoplastic surgical procedures.

METHODS:

A retrospective chart review was performed for all oncoplastic breast operations within a single health system from 2015 to 2021. Patients were stratified by age, with patients 65 years and older (OBS65+) identified and then matched with younger patients (OBS <65) based on BMI. Primary outcomes were positive margin rates and overall complication rates; secondary outcomes were locoregional recurrence (LR), distant recurrence (DR), disease-free survival (DFS), overall survival (OS), and long-term breast asymmetry.

RESULTS:

A total of 217 patients underwent OBS over the 6-year period, with 22% being OBS65+. Preoperatively, older patients experienced higher American Anesthesia (ASA) scores, Charlson Co-morbidity index (CCI) scores, and higher rates of diabetes mellitus, hypertension, and grade 3 breast ptosis. Despite this, no significant differences were found between primary or secondary outcomes compared to younger patients undergoing the same procedures.

CONCLUSIONS:

Oncoplastic breast reconstruction is a safe option in patients 65 years and older, with overall similar recurrence rates, positive margin rates, and survival when compared to younger patients. Although the older cohort of patients had greater preoperative risk, there was no difference in overall surgical complication rates or outcomes. Supporting the argument that all oncoplastic breast reconstruction techniques should be offered to eligible patients, irrespective of age.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mastectomy, Segmental / Mammaplasty Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ann Plast Surg Year: 2024 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mastectomy, Segmental / Mammaplasty Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ann Plast Surg Year: 2024 Document type: Article Country of publication: Estados Unidos